{"id":999778,"date":"2026-09-02T09:00:52","date_gmt":"2026-09-02T13:00:52","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/spyglass-pharma-to-participate-in-upcoming-investor-conferences-2\/"},"modified":"2026-09-02T09:00:52","modified_gmt":"2026-09-02T13:00:52","slug":"spyglass-pharma-to-participate-in-upcoming-investor-conferences-2","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/spyglass-pharma-to-participate-in-upcoming-investor-conferences-2\/","title":{"rendered":"SpyGlass Pharma to Participate in Upcoming Investor Conferences"},"content":{"rendered":"<div class=\"mw_release\">\n<p>IRVINE, Calif., Sept.  02, 2026  (GLOBE NEWSWIRE) &#8212; SpyGlass Pharma, Inc. (Nasdaq: SGP) (\u201cSpyGlass Pharma\u201d or \u201cCompany\u201d), a late-stage biopharmaceutical company, today announced that members of the executive management team will participate in the following upcoming conferences:<\/p>\n<p>\n        <strong><br \/>\n          <u>Wells Fargo 21<\/u><br \/>\n        <\/strong><br \/>\n        <sup><br \/>\n          <strong><br \/>\n            <u>st<\/u><br \/>\n          <\/strong><br \/>\n        <\/sup><br \/>\n        <strong><br \/>\n          <u> Annual Healthcare Conference<\/u><br \/>\n        <\/strong><br \/>\n        <br \/>Date: Wednesday, September 9, 2026 <br \/>Format: 1&#215;1 Meetings only<\/p>\n<p>\n        <strong><br \/>\n          <u>Citi\u2019s 2026 Biopharma Back to School Conference<\/u><br \/>\n        <\/strong><br \/>\n        <br \/>Date: Thursday, September 10, 2026<br \/>Time: 10:40 a.m. ET<br \/>Format: Fireside Chat and 1&#215;1 Meetings<\/p>\n<p>\n        <strong><br \/>\n          <u>H.C. Wainwright 28<\/u><br \/>\n        <\/strong><br \/>\n        <sup><br \/>\n          <strong><br \/>\n            <u>th<\/u><br \/>\n          <\/strong><br \/>\n        <\/sup><br \/>\n        <strong><br \/>\n          <u> Annual Global Investment Conference<\/u><br \/>\n        <\/strong><br \/>\n        <br \/>Date: Monday, September 14, 2026<br \/>Time: 1:30 p.m. ET<br \/>Format: Corporate Presentation &amp; 1&#215;1 Meetings<\/p>\n<p>A live webcast and subsequent replay of the Citi fireside chat and H.C. Wainwright presentation can be accessed via the Investor Relations section of the Company website at <u>www.spyglasspharma.com<\/u>.<\/p>\n<p>\n        <strong>About SpyGlass Pharma<\/strong>\n      <\/p>\n<p>SpyGlass Pharma is a late-stage biopharmaceutical company dedicated to transforming the treatment paradigm for patients living with chronic eye conditions through long-acting, sustained drug delivery of approved medicines. The Company\u2019s mission is to significantly improve the lives of patients with chronic eye conditions by developing durable drug delivery solutions that can empower patients and surgeons with confidence in long-term disease control and vision preservation.<\/p>\n<p>The SpyGlass Pharma platform, a novel, non-bioerodible drug delivery technology, is designed to be used with various well-established, approved medicines, including bimatoprost and other small molecules, providing flexibility to potentially treat a range of conditions in the front and back of the eye.<\/p>\n<p>The Company was founded in 2019 by Malik Y. Kahook, M.D. and Glenn Sussman to solve the lack of ophthalmic innovations that capitalize on durable treatment options. The SpyGlass Pharma platform was originally developed in the Sue Anschutz-Rodgers Eye Center at the University of Colorado Anschutz School of Medicine.<\/p>\n<p>\n        <strong>Media Contact:<\/strong><br \/>\n        <br \/>Nami Surendranath<br \/>+1 (402) 507-6757<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=BytuiVoxloJpoTkzm_NMLlALsS7j1gUVh49M65mxarCeD-zkl236K2E7Rr6NsCjuKanBEMthk79sF-VTBcmHs74JWDrKdLcLmjAtt5ZgyW4y4LlKDySIj8Kr1RY6ZfdOjVTYR_5iYrsPnm3dH3HRpw==\" rel=\"nofollow\" target=\"_blank\"><u>nsurendranath@dnacommunications.com<\/u><\/a><\/p>\n<p>\n        <strong>Investor Contact:<\/strong><br \/>\n        <br \/>Ami Bavishi or Nick Colangelo<br \/>Gilmartin Group LLC<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=j3ZvhXVBHr4muFP0DiOb-McuPePbZXIZWa8EBeUr3BJ72aSOY-fMTdKM62J6HmrJZZGQzDQ54k-ytbYXgZpjwwrisBOd4MBNg8qu7kuJDKSWAylII-I4je4hQRvgsJ0w\" rel=\"nofollow\" target=\"_blank\">investors@spyglasspharma.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgxODg5NyM3ODA3OTE0IzIyNTI0NjY=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/OTA0OGNhODQtMmIwYi00NzJlLWE3MmUtNTNmOWZiM2E0ZDc1LTEyNjQwMTktMjAyNi0wOS0wMi1lbg==\/tiny\/Spyglass-Pharma-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>IRVINE, Calif., Sept. 02, 2026 (GLOBE NEWSWIRE) &#8212; SpyGlass Pharma, Inc. (Nasdaq: SGP) (\u201cSpyGlass Pharma\u201d or \u201cCompany\u201d), a late-stage biopharmaceutical company, today announced that members of the executive management team will participate in the following upcoming conferences: Wells Fargo 21 st Annual Healthcare Conference Date: Wednesday, September 9, 2026 Format: 1&#215;1 Meetings only Citi\u2019s 2026 Biopharma Back to School Conference Date: Thursday, September 10, 2026Time: 10:40 a.m. ETFormat: Fireside Chat and 1&#215;1 Meetings H.C. Wainwright 28 th Annual Global Investment Conference Date: Monday, September 14, 2026Time: 1:30 p.m. ETFormat: Corporate Presentation &amp; 1&#215;1 Meetings A live webcast and subsequent replay of the Citi fireside chat and H.C. Wainwright presentation can be accessed via the Investor Relations section of the Company &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/spyglass-pharma-to-participate-in-upcoming-investor-conferences-2\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;SpyGlass Pharma to Participate in Upcoming Investor Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-999778","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>SpyGlass Pharma to Participate in Upcoming Investor Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/spyglass-pharma-to-participate-in-upcoming-investor-conferences-2\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"SpyGlass Pharma to Participate in Upcoming Investor Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"IRVINE, Calif., Sept. 02, 2026 (GLOBE NEWSWIRE) &#8212; SpyGlass Pharma, Inc. (Nasdaq: SGP) (\u201cSpyGlass Pharma\u201d or \u201cCompany\u201d), a late-stage biopharmaceutical company, today announced that members of the executive management team will participate in the following upcoming conferences: Wells Fargo 21 st Annual Healthcare Conference Date: Wednesday, September 9, 2026 Format: 1&#215;1 Meetings only Citi\u2019s 2026 Biopharma Back to School Conference Date: Thursday, September 10, 2026Time: 10:40 a.m. ETFormat: Fireside Chat and 1&#215;1 Meetings H.C. Wainwright 28 th Annual Global Investment Conference Date: Monday, September 14, 2026Time: 1:30 p.m. ETFormat: Corporate Presentation &amp; 1&#215;1 Meetings A live webcast and subsequent replay of the Citi fireside chat and H.C. Wainwright presentation can be accessed via the Investor Relations section of the Company &hellip; Continue reading &quot;SpyGlass Pharma to Participate in Upcoming Investor Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/spyglass-pharma-to-participate-in-upcoming-investor-conferences-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-09-02T13:00:52+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgxODg5NyM3ODA3OTE0IzIyNTI0NjY=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spyglass-pharma-to-participate-in-upcoming-investor-conferences-2\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spyglass-pharma-to-participate-in-upcoming-investor-conferences-2\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"SpyGlass Pharma to Participate in Upcoming Investor Conferences\",\"datePublished\":\"2026-09-02T13:00:52+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spyglass-pharma-to-participate-in-upcoming-investor-conferences-2\\\/\"},\"wordCount\":307,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spyglass-pharma-to-participate-in-upcoming-investor-conferences-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgxODg5NyM3ODA3OTE0IzIyNTI0NjY=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spyglass-pharma-to-participate-in-upcoming-investor-conferences-2\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spyglass-pharma-to-participate-in-upcoming-investor-conferences-2\\\/\",\"name\":\"SpyGlass Pharma to Participate in Upcoming Investor Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spyglass-pharma-to-participate-in-upcoming-investor-conferences-2\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spyglass-pharma-to-participate-in-upcoming-investor-conferences-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgxODg5NyM3ODA3OTE0IzIyNTI0NjY=\",\"datePublished\":\"2026-09-02T13:00:52+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spyglass-pharma-to-participate-in-upcoming-investor-conferences-2\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spyglass-pharma-to-participate-in-upcoming-investor-conferences-2\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spyglass-pharma-to-participate-in-upcoming-investor-conferences-2\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgxODg5NyM3ODA3OTE0IzIyNTI0NjY=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgxODg5NyM3ODA3OTE0IzIyNTI0NjY=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spyglass-pharma-to-participate-in-upcoming-investor-conferences-2\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"SpyGlass Pharma to Participate in Upcoming Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"SpyGlass Pharma to Participate in Upcoming Investor Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/spyglass-pharma-to-participate-in-upcoming-investor-conferences-2\/","og_locale":"en_US","og_type":"article","og_title":"SpyGlass Pharma to Participate in Upcoming Investor Conferences - Market Newsdesk","og_description":"IRVINE, Calif., Sept. 02, 2026 (GLOBE NEWSWIRE) &#8212; SpyGlass Pharma, Inc. (Nasdaq: SGP) (\u201cSpyGlass Pharma\u201d or \u201cCompany\u201d), a late-stage biopharmaceutical company, today announced that members of the executive management team will participate in the following upcoming conferences: Wells Fargo 21 st Annual Healthcare Conference Date: Wednesday, September 9, 2026 Format: 1&#215;1 Meetings only Citi\u2019s 2026 Biopharma Back to School Conference Date: Thursday, September 10, 2026Time: 10:40 a.m. ETFormat: Fireside Chat and 1&#215;1 Meetings H.C. Wainwright 28 th Annual Global Investment Conference Date: Monday, September 14, 2026Time: 1:30 p.m. ETFormat: Corporate Presentation &amp; 1&#215;1 Meetings A live webcast and subsequent replay of the Citi fireside chat and H.C. Wainwright presentation can be accessed via the Investor Relations section of the Company &hellip; Continue reading \"SpyGlass Pharma to Participate in Upcoming Investor Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/spyglass-pharma-to-participate-in-upcoming-investor-conferences-2\/","og_site_name":"Market Newsdesk","article_published_time":"2026-09-02T13:00:52+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgxODg5NyM3ODA3OTE0IzIyNTI0NjY=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/spyglass-pharma-to-participate-in-upcoming-investor-conferences-2\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/spyglass-pharma-to-participate-in-upcoming-investor-conferences-2\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"SpyGlass Pharma to Participate in Upcoming Investor Conferences","datePublished":"2026-09-02T13:00:52+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/spyglass-pharma-to-participate-in-upcoming-investor-conferences-2\/"},"wordCount":307,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/spyglass-pharma-to-participate-in-upcoming-investor-conferences-2\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgxODg5NyM3ODA3OTE0IzIyNTI0NjY=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/spyglass-pharma-to-participate-in-upcoming-investor-conferences-2\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/spyglass-pharma-to-participate-in-upcoming-investor-conferences-2\/","name":"SpyGlass Pharma to Participate in Upcoming Investor Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/spyglass-pharma-to-participate-in-upcoming-investor-conferences-2\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/spyglass-pharma-to-participate-in-upcoming-investor-conferences-2\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgxODg5NyM3ODA3OTE0IzIyNTI0NjY=","datePublished":"2026-09-02T13:00:52+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/spyglass-pharma-to-participate-in-upcoming-investor-conferences-2\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/spyglass-pharma-to-participate-in-upcoming-investor-conferences-2\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/spyglass-pharma-to-participate-in-upcoming-investor-conferences-2\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgxODg5NyM3ODA3OTE0IzIyNTI0NjY=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgxODg5NyM3ODA3OTE0IzIyNTI0NjY="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/spyglass-pharma-to-participate-in-upcoming-investor-conferences-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"SpyGlass Pharma to Participate in Upcoming Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/999778","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=999778"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/999778\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=999778"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=999778"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=999778"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}